Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Brian Ko, M.D.

Medical Officer

Investigational Drug Branch

NCI Division of Cancer Treatment and Diagnosis (DCTD) Cancer Therapy Evaluation Program (CTEP)

240-276-6565

Brian.ko@nih.gov

Dr. Brian Ko joined the Investigational Drug Branch (IDB) at the National Cancer Institute (NCI) in 2024. He earned his undergraduate degree from Harvard University and his M.D. from the University of Illinois. He completed his internal medicine residency and medical oncology/hematology fellowship at Montefiore Einstein. He then undertook further subspeciality training in early phase cancer clinical trials and oncologic drug development at the Advanced Developmental Therapeutics Training Program at NCI.